期刊文献+

肾交感神经射频消融术对高血压犬去甲肾上腺素溢出率及交感神经活性的影响 被引量:3

Effects of renal sympathetic nerve radiofrequency ablation on norepinephrine spillover rate and sympathetic nerve activity in dogs with hypertension
下载PDF
导出
摘要 目的评价肾交感神经射频消融术(RSD)治疗腹主动脉缩窄型高血压犬的有效性和作用机制。方法成年健康杂种犬20只,采用腹主动脉缩窄法建立高血压模型。模型建立后,随机分为治疗组(n=10)和对照组(n=10)。治疗组犬于建模后1个月行双侧肾交感神经射频消融术。分别于建立模型前和建立模型后1、2、3个月,测定犬前上臂血压、交感神经活性及去甲肾上腺素溢出率并观察其变化趋势。结果建模后1个月,对照组前上臂收缩压(SBP)、舒张压(DBP)和平均动脉压(MAP)与建模前比较均明显升高(P<0.05),肾交感神经活性冲动明显增强,去甲肾上腺素溢出率水平明显增高(P<0.05)。治疗组RSD手术即刻肾交感神经活性明显下降,至消融后2个月略有增高;去甲肾上腺素溢出率水平在建模后1个月显著增高(P<0.05),消融后显著降低并一直持续至实验结束(P<0.05)。与对照组比较,治疗组消融后1个月、2个月去甲肾上腺素溢出率水平显著降低(P<0.05)。结论 RSD对于高血压犬去甲肾上腺素溢出率及交感神经活性均有明显抑制作用。 Objective To evaluate the validity and explore the mechanism of renal sympathetic denervation (RSD) in the treatment of dogs with hypertension reproduced by constriction of abdominal aorta. Methods The hypertension model was reproduced by constriction of abdominal aorta in 20 adult healthy dogs. These dogs were then randomly divided into the treatment group and control group (10 each). Renal sympathetic nerve radiofrequency ablation was done in treatment group 1 month after modeling. The foreleg blood pressure, sympathetic activity and norepinephrine overflow rate of dogs in two groups were detected before modeling, and 1, 2 and 3 months after modeling, and the trend of the change was also observed. Results One month after modeling, the systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial blood pressure (MAP) were elevated significantly in control group (146.7 ± 21.0, 89.0 ± 12.7 and 108.3 ± 14.9mmHg) compared with those before modeling (119.5 ± 13.2, 76.5 ± 7.8 and 90.9 ± 8mmHg, P〈0.05). The renal sympathetic activity impulse and norepinephrine spillover rate were also enhanced significantly (P〈0.05). The renal sympathetic nerve activity obviously decreased in the treatment group after the operation, and then increased 2 months after the ablation. The norepinephrine spillover rate in treatment group increased significantly 1 month after modeling (P〈0.05), and decreased after ablation, and it lasted to the end of the experiment (P〈0.05). One and two months after ablation, the norepinephrine spillover rate was lower in treatment group than in control group (P〈0.05). Conclusion Renal sympathetic nerve radiofrequency ablation significantly inhibits the elevation of norepinephrine spillover rate and sympathetic nerve activity in dogs with hypertension.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2012年第11期1050-1053,共4页 Medical Journal of Chinese People's Liberation Army
关键词 高血压 导管消融术 去甲肾上腺素 交感神经系统 hypertension catheter ablation norepinephrine sympathetic nervous system
  • 相关文献

参考文献9

  • 1Krum H, Schlaich M, Whitboum R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet, 2009, 373(9671): 1275-1281.
  • 2Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months[J]. Hypertension, 2011, 57(5): 911-917.
  • 3Symplicity HTN-2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial[J]. Lancet, 2010, 376(9756): 1903-1909.
  • 4Calhoun DA, Jones D, Textor S, et al. Resistant hypertension:diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research[J]. Hypertension, 2008, 51(6): 1403-1414.
  • 5Morrissey DM, Brookes, Vooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases[J]. Lancet, 1953, 1(6757): 403-408.
  • 6Peet MM. Hypertension and its surgical treatment by bilateral supradiaphragmatic splanchnicectomy[J]. Am J Surg, 1948, 75(1): 48-68.
  • 7Paulis L, Unger T. Novel therapeutic targets for hypertension[J]. Cardiol, 2010, 7(8): 431-441.
  • 8Schlaich MP, Krum H, Sobotka PA, et al. Renal denervation and Hypertension[J]. AmJ Hypertens, 2011, 24(6): 635-642.
  • 9庞博,付兆君,谈维洁,刘朝中,黄丛春,徐先荣,陆承荣,孙津津,王刚.肾性高血压大鼠动脉收缩、舒张功能改变的研究[J].解放军医学杂志,2010,35(3):293-296. 被引量:3

二级参考文献11

  • 1谢泓(综述),谢良地(审校).体循环和肺循环高压中血管张力相关离子通道的重构[J].高血压杂志,2006,14(5):343-345. 被引量:3
  • 2郭益民,陈然,李旭,张玉青.一氧化氮对肾性高血压大鼠主动脉收缩功能的影响[J].中国病理生理杂志,2006,22(7):1378-1381. 被引量:4
  • 3Risler NR, Cruzado MC, Miatello RM, et al. Vascular remodeling in experimental hypertension[J]. Sci World J, 2005, 5: 959-971.
  • 4Fu ZJ, Xie MJ, Zhang LF, et al. Differential activation of potassium channels in cerebral and hindquarter arteries of rats during simulated mierogravity[J]. Am J Physiol Heart Cire Physiol, 2004, 287(4): H1505-H1515.
  • 5Baranowska M, Kozlowska H, Korbut A, et al. Potassium channds in blood vessels: their role in health and disease[J]. Postepy Hig Med Dosw(online), 2007, 61:596 605.
  • 6Cox RH, Rusch NJ. New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure[J]. Microcirculation, 2002, 9(4): 243-257.
  • 7Bratz IN, Swafford AN Jr, Kanagy NL, et al. Reduced functional expression of K channels in vascular smooth muscle tells from rats made hypertensive with N{omega}-nitro-L-arginine[J]. AM J Physiol Heart Cite Physiol, 2005, 289(3): H1284-H1290.
  • 8Amberg GC, Bonev AD, Rossow CF, et al. Modulation of the molecular composition of large conductance, Ca^2+ activated K^+ channels in vascular smooth muscle during hypertension[J]. J Clin Invest, 2003, 112(5): 717-724.
  • 9Amberg GC, Santana LF. Downregulation of the BK channel β1 subunit in genetic hypertension[J]. Circ Res, 2003, 93(10): 965-971.
  • 10李悦梅.高血压血管重构的研究进展[J].中国动脉硬化杂志,2003,11(2):171-174. 被引量:33

共引文献2

同被引文献61

  • 1卢成志,赵斌,王丽,罗迪.经导管射频消融法去肾动脉交感神经治疗顽固性高血压[J].中国医学前沿杂志(电子版),2012,4(2):18-23. 被引量:5
  • 2张锦明,田嘉禾,川玲,刘自来.心肌摄取^(131)I-MIBG的影响因素[J].中华核医学杂志,1997,17(2):91-93. 被引量:1
  • 3Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure[J]. Eur Heart J, 2012, 33(9): 1058-1066.
  • 4Grassi G, Bertoli S, Seravalle G, et al. Sympathetic nervous sys- tem:role in hypertension and in chronic kidney disease[J]. Curr Opin Nephrol Hypertens, 2012,21 (1) : 46-51.
  • 5Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months[J]. Hypertension, 2011,57 (5): 911-917.
  • 6Christensen NJ. Methods of studying sympathoadrenal activity in man[J]. Acta Med Stand,1988,223(6) :481-483.
  • 7Axelro J, Reisine TD. Stress hormones: their interaction and reg- ulation[J]. Science, 1984,224(4648) :452-459.
  • 8Grassi G, Seravalle G, Brambilla G, et al. The sympathetic nerv- ous system and new nonpharmacologic approaches to treating hy- pertension:a focus on renal denervation[J]. Can J Cardiol,2012,28(3):311-317.
  • 9Hausberg M, Kosch M, Harmdink P, et al. Sympathetic nerve activity in end-stage renal disease[J]. Circulation, 2002,106 (15) :1974-1979.
  • 10Kotanko P. Cause and consequences of sympathetic hyperactivity in chronic kidney disease[J]. Blood Purif,2006,24(1) :95-99.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部